- Presentations
- 3
- Markets
- 1
Exjade is a brand of Deferasirox marketed by Novartis Pharmaceuticals, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Deferasirox
- Brand owner
- Novartis Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 125 mg tablet for oral suspension, 250 mg tablet for oral suspension, 500 mg tablet for oral suspension
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Exjade 125 mg tablet for oral suspensionOral | Novartis Pharmaceuticals | US FDA | Available on request |
| Exjade 250 mg tablet for oral suspensionOral | Novartis Pharmaceuticals | US FDA | Available on request |
| Exjade 500 mg tablet for oral suspensionOral | Novartis Pharmaceuticals | US FDA | Available on request |
Equivalent brands
Other brands of Deferasirox.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Exjade
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.